Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Velocity Clinical Research - Savannah, Georgia

Verified

Basic Information

Site Overview

Source: Human-provided.

Velocity Clinical Research at Urological Associates of Savannah is a specialized clinical trial research site located in Savannah, Georgia, United States. The facility operates in collaboration with Urological Associates of Savannah and is part of the global Velocity Clinical Research network, an integrated site organization that partners with pharmaceutical and biotechnology companies to conduct clinical trials for new drugs, medical devices, and therapeutic interventions. The research site focuses primarily on clinical studies related to urology, including conditions such as prostate disorders, urinary tract diseases, kidney conditions, and men’s health. In addition to urology-focused research, the center may participate in broader clinical trials depending on study requirements and sponsor collaborations. The site is supported by experienced physician investigators, clinical research coordinators, and trained healthcare professionals who ensure that studies are conducted…

Source: Trial-derived.
11Total Trials
Source: Trial-derived.
0Recruiting Trials
Source: Trial-derived.
4Active Trials
Source: Trial-derived.
7Completed Trials
Source: Trial-derived.
9Unique Conditions
Source: Trial-derived.
9Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. COVID-19 (2)Source: Trial-derived. Hypertension (2)Source: Trial-derived. Relapsing Multiple Sclerosis (2)Source: Trial-derived. Epstein-Barr Virus Infection (1)Source: Trial-derived. Hypogonadism (1)Source: Trial-derived. Infectious Disease (1)Source: Trial-derived. Influenza (1)Source: Trial-derived. Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention (1)

Sponsors

Source: Trial-derived. ICON plc (2)Source: Trial-derived. ModernaTX, Inc. (2)Source: Trial-derived. Novartis Pharmaceuticals (2)Source: Trial-derived. Sanofi (2)Source: Trial-derived. Immorna Biotherapeutics, Inc. (1)Source: Trial-derived. Janssen Research & Development, LLC (1)Source: Trial-derived. Kardigan, Inc. (1)Source: Trial-derived. Novavax (1)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. MRI

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Amenities

Amenities Available

Source: Google. Restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Nine-hole peg test
Source: AI-inferred. Serum neurofilament light chain (NfL) quantification
Source: AI-inferred. Timed 25-foot walk test
Source: AI-inferred. Vaccine antibody titre serology